Competing approaches to drug pricing in the 2024 election
Linked media - Related media The future of drug pricing policies in the US hinges on the outcome of the 2024 election, with the Democratic and Republican candidates presenting distinct approaches. Vice President Kamala Harris aims to expand upon the Biden administration’s existing policies, while former President Donald Trump’s stance remains less defined. Harris has pledged to broaden the scope of Medicare drug price negotiations, a key achievement of the Biden presidency, to include more medications and benefit a wider population. She intends to utilize the resulting savings to fund an ambitious new proposal for long-term at-home care coverage under…
